Buzz
Researchers have achieved a breakthrough by editing the genes of viable human embryos to correct mutations linked to a life-threatening heart condition. Their groundbreaking findings were published in the renowned journal Nature.
The revolutionary CRISPR-Cas9 gene-editing tool has consistently made headlines. It has been utilized to create miniature pigs, diagnose diseases, and even store GIFs within bacterial DNA. As the technology evolves, scientists are increasingly exploring its potential applications in human genetics.
In this groundbreaking study, a global team of scientists fertilized healthy human eggs with sperm from men carrying a mutation for hypertrophic cardiomyopathy, a condition that can cause sudden death in young individuals. The mutation affects the MYBPC3 gene and is dominant, meaning only one faulty copy is needed for the disease to manifest.
Alternatively, this implies that scientists could, in theory, eliminate the disease by repairing the single faulty gene copy.
Eighteen hours post-fertilization, the researchers employed CRISPR-Cas9 to precisely cut out the defective MYBPC3 genes in certain embryos and substitute them with healthy versions. After three days, they examined the results, observing the embryos—still microscopic clusters of cells—to assess the outcome.
The procedure appeared to be effective. A notable proportion of the edited embryos showed no signs of the mutation or the associated disease compared to the control group. Additionally, the researchers detected no unintended mutations caused by their intervention, though the possibility of overlooked mutations remains.
Our capability to modify human genes is advancing rapidly. However, many ethicists contend that the ability to do so does not necessarily justify its use. In the United States, government-funded research is barred from editing the germline of human embryos, but privately funded projects, like this one, face no such restrictions.
On the same day the study was released, a global panel of genetics experts issued a unified statement recommending against editing embryos intended for implantation, which could lead to pregnancy and birth.
"While germline genome editing holds the potential to prevent genetic diseases in unborn children, it also introduces a host of scientific, ethical, and policy dilemmas,” stated Derek T. Scholes of the American Society of Human Genetics. “These issues cannot be resolved solely by scientists; they require broader societal discussion."
Ethicists and sociologists warn about the dangers of pursuing the creation of an 'improved' human. Many individuals with chronic illnesses or disabilities lead fulfilling lives and often find that societal discrimination poses greater challenges than their medical conditions.
Lennard Davis, a disability studies expert at the University of Illinois, emphasizes that scientific advancements cannot be divorced from society’s history of marginalizing and oppressing individuals with disabilities and illnesses.
“Much of this groundbreaking science and technology must consider that perceptions of life for those who are different are often rooted in disability prejudice,” he remarked to Nature in 2016.
Rosemary Garland-Thomson, co-director of the Disability Studies Initiative at Emory University, told Nature that humanity stands at a critical ethical and cultural juncture: “We are dangerously close to deciding which ways of existing in the world should be eradicated.”
